On Tuesday, Vincerx Pharma Inc (NASDAQ: VINC) was -3.55% drop from the session before settling in for the closing price of $0.35. A 52-week range for VINC has been $0.32 – $9.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 55.56%. With a float of $24.94 million, this company’s outstanding shares have now reached $33.56 million.
Let’s look at the performance matrix of the company that is accounted for 42 employees. In terms of profitability, gross margin is 20.4%, operating margin of -2335.92%, and the pretax margin is -2199.54%.
Vincerx Pharma Inc (VINC) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vincerx Pharma Inc stocks. The insider ownership of Vincerx Pharma Inc is 25.69%, while institutional ownership is 31.84%.
Vincerx Pharma Inc (VINC) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.46 earnings per share (EPS) during the time that was better than consensus figure (set at -0.46) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 55.56% per share during the next fiscal year.
Vincerx Pharma Inc (NASDAQ: VINC) Trading Performance Indicators
You can see what Vincerx Pharma Inc (VINC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Vincerx Pharma Inc (VINC)
Vincerx Pharma Inc (NASDAQ: VINC) saw its 5-day average volume 0.46 million, a negative change from its year-to-date volume of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 34.37%. Additionally, its Average True Range was 0.04.
During the past 100 days, Vincerx Pharma Inc’s (VINC) raw stochastic average was set at 4.29%, which indicates a significant decrease from 24.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.46% in the past 14 days, which was lower than the 113.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5341, while its 200-day Moving Average is $1.5268. Nevertheless, the first resistance level for the watch stands at $0.3697 in the near term. At $0.4000, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4200. If the price goes on to break the first support level at $0.3194, it is likely to go to the next support level at $0.2994. The third support level lies at $0.2691 if the price breaches the second support level.
Vincerx Pharma Inc (NASDAQ: VINC) Key Stats
There are 29,672K outstanding shares of the company, which has a market capitalization of 11.39 million. As of now, sales total 0 K while income totals -40,160 K. Its latest quarter income was 0 K while its last quarter net income were -1,810 K.
